nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0874	0.226	CbGbCtD
Hydromorphone—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0836	0.216	CbGbCtD
Hydromorphone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0523	0.135	CbGbCtD
Hydromorphone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0486	0.126	CbGbCtD
Hydromorphone—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0358	0.0927	CbGbCtD
Hydromorphone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0223	0.0578	CbGbCtD
Hydromorphone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0219	0.0568	CbGbCtD
Hydromorphone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0205	0.0529	CbGbCtD
Hydromorphone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.014	0.0361	CbGbCtD
Hydromorphone—Naltrexone—ABCB1—peripheral nervous system neoplasm	0.000851	0.349	CrCbGaD
Hydromorphone—Naloxone—ABCB1—peripheral nervous system neoplasm	0.000621	0.255	CrCbGaD
Hydromorphone—Morphine—ABCB1—peripheral nervous system neoplasm	0.000524	0.215	CrCbGaD
Hydromorphone—Dextromethorphan—ABCB1—peripheral nervous system neoplasm	0.00044	0.181	CrCbGaD
Hydromorphone—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000437	CcSEcCtD
Hydromorphone—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000437	CcSEcCtD
Hydromorphone—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000433	CcSEcCtD
Hydromorphone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000264	0.000433	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000431	CcSEcCtD
Hydromorphone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000263	0.000431	CcSEcCtD
Hydromorphone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000262	0.000429	CcSEcCtD
Hydromorphone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.000428	CcSEcCtD
Hydromorphone—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000428	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000261	0.000428	CcSEcCtD
Hydromorphone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000259	0.000424	CcSEcCtD
Hydromorphone—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000424	CcSEcCtD
Hydromorphone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000259	0.000424	CcSEcCtD
Hydromorphone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000422	CcSEcCtD
Hydromorphone—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000418	CcSEcCtD
Hydromorphone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000255	0.000417	CcSEcCtD
Hydromorphone—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000417	CcSEcCtD
Hydromorphone—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000414	CcSEcCtD
Hydromorphone—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000414	CcSEcCtD
Hydromorphone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000413	CcSEcCtD
Hydromorphone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000252	0.000413	CcSEcCtD
Hydromorphone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.000411	CcSEcCtD
Hydromorphone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00025	0.000408	CcSEcCtD
Hydromorphone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000249	0.000408	CcSEcCtD
Hydromorphone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000405	CcSEcCtD
Hydromorphone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000247	0.000405	CcSEcCtD
Hydromorphone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000247	0.000404	CcSEcCtD
Hydromorphone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000246	0.000402	CcSEcCtD
Hydromorphone—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000399	CcSEcCtD
Hydromorphone—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000399	CcSEcCtD
Hydromorphone—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000399	CcSEcCtD
Hydromorphone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000244	0.000399	CcSEcCtD
Hydromorphone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000243	0.000398	CcSEcCtD
Hydromorphone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000242	0.000395	CcSEcCtD
Hydromorphone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000241	0.000395	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00024	0.000392	CcSEcCtD
Hydromorphone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000239	0.000392	CcSEcCtD
Hydromorphone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000239	0.000391	CcSEcCtD
Hydromorphone—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000389	CcSEcCtD
Hydromorphone—Constipation—Etoposide—peripheral nervous system neoplasm	0.000237	0.000388	CcSEcCtD
Hydromorphone—Pain—Etoposide—peripheral nervous system neoplasm	0.000237	0.000388	CcSEcCtD
Hydromorphone—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000387	CcSEcCtD
Hydromorphone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000235	0.000385	CcSEcCtD
Hydromorphone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000234	0.000383	CcSEcCtD
Hydromorphone—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000382	CcSEcCtD
Hydromorphone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000382	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000377	CcSEcCtD
Hydromorphone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000375	CcSEcCtD
Hydromorphone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000229	0.000374	CcSEcCtD
Hydromorphone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000228	0.000373	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000227	0.000371	CcSEcCtD
Hydromorphone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000226	0.000371	CcSEcCtD
Hydromorphone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000226	0.00037	CcSEcCtD
Hydromorphone—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000369	CcSEcCtD
Hydromorphone—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000369	CcSEcCtD
Hydromorphone—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000369	CcSEcCtD
Hydromorphone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.000367	CcSEcCtD
Hydromorphone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.000366	CcSEcCtD
Hydromorphone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000223	0.000365	CcSEcCtD
Hydromorphone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000365	CcSEcCtD
Hydromorphone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000223	0.000364	CcSEcCtD
Hydromorphone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00022	0.000361	CcSEcCtD
Hydromorphone—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00036	CcSEcCtD
Hydromorphone—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000359	CcSEcCtD
Hydromorphone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000219	0.000359	CcSEcCtD
Hydromorphone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000219	0.000359	CcSEcCtD
Hydromorphone—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000356	CcSEcCtD
Hydromorphone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000218	0.000356	CcSEcCtD
Hydromorphone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000217	0.000355	CcSEcCtD
Hydromorphone—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000354	CcSEcCtD
Hydromorphone—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000354	CcSEcCtD
Hydromorphone—Rash—Vincristine—peripheral nervous system neoplasm	0.000216	0.000353	CcSEcCtD
Hydromorphone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000216	0.000353	CcSEcCtD
Hydromorphone—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000353	CcSEcCtD
Hydromorphone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000352	CcSEcCtD
Hydromorphone—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000351	CcSEcCtD
Hydromorphone—Headache—Vincristine—peripheral nervous system neoplasm	0.000215	0.000351	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000349	CcSEcCtD
Hydromorphone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.000345	CcSEcCtD
Hydromorphone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000345	CcSEcCtD
Hydromorphone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000207	0.000339	CcSEcCtD
Hydromorphone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000337	CcSEcCtD
Hydromorphone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000335	CcSEcCtD
Hydromorphone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000204	0.000334	CcSEcCtD
Hydromorphone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000334	CcSEcCtD
Hydromorphone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000203	0.000333	CcSEcCtD
Hydromorphone—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000332	CcSEcCtD
Hydromorphone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000332	CcSEcCtD
Hydromorphone—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000332	CcSEcCtD
Hydromorphone—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.00033	CcSEcCtD
Hydromorphone—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000327	CcSEcCtD
Hydromorphone—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000326	CcSEcCtD
Hydromorphone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000199	0.000326	CcSEcCtD
Hydromorphone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000326	CcSEcCtD
Hydromorphone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000325	CcSEcCtD
Hydromorphone—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000325	CcSEcCtD
Hydromorphone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000323	CcSEcCtD
Hydromorphone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000323	CcSEcCtD
Hydromorphone—Chills—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000321	CcSEcCtD
Hydromorphone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000196	0.000321	CcSEcCtD
Hydromorphone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00032	CcSEcCtD
Hydromorphone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000319	CcSEcCtD
Hydromorphone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000193	0.000315	CcSEcCtD
Hydromorphone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000314	CcSEcCtD
Hydromorphone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000312	CcSEcCtD
Hydromorphone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000312	CcSEcCtD
Hydromorphone—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000312	CcSEcCtD
Hydromorphone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000312	CcSEcCtD
Hydromorphone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00019	0.000311	CcSEcCtD
Hydromorphone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00031	CcSEcCtD
Hydromorphone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000309	CcSEcCtD
Hydromorphone—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000308	CcSEcCtD
Hydromorphone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000308	CcSEcCtD
Hydromorphone—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000307	CcSEcCtD
Hydromorphone—Tension—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000306	CcSEcCtD
Hydromorphone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000305	CcSEcCtD
Hydromorphone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000303	CcSEcCtD
Hydromorphone—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000302	CcSEcCtD
Hydromorphone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000301	CcSEcCtD
Hydromorphone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000183	0.0003	CcSEcCtD
Hydromorphone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000183	0.0003	CcSEcCtD
Hydromorphone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000299	CcSEcCtD
Hydromorphone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000299	CcSEcCtD
Hydromorphone—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000297	CcSEcCtD
Hydromorphone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000296	CcSEcCtD
Hydromorphone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00018	0.000294	CcSEcCtD
Hydromorphone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000294	CcSEcCtD
Hydromorphone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.00029	CcSEcCtD
Hydromorphone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000289	CcSEcCtD
Hydromorphone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000176	0.000289	CcSEcCtD
Hydromorphone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000288	CcSEcCtD
Hydromorphone—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000288	CcSEcCtD
Hydromorphone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000287	CcSEcCtD
Hydromorphone—Rash—Etoposide—peripheral nervous system neoplasm	0.000175	0.000286	CcSEcCtD
Hydromorphone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000175	0.000286	CcSEcCtD
Hydromorphone—Headache—Etoposide—peripheral nervous system neoplasm	0.000174	0.000284	CcSEcCtD
Hydromorphone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000284	CcSEcCtD
Hydromorphone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000283	CcSEcCtD
Hydromorphone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000282	CcSEcCtD
Hydromorphone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000281	CcSEcCtD
Hydromorphone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.00028	CcSEcCtD
Hydromorphone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00028	CcSEcCtD
Hydromorphone—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00028	CcSEcCtD
Hydromorphone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000279	CcSEcCtD
Hydromorphone—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000279	CcSEcCtD
Hydromorphone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000277	CcSEcCtD
Hydromorphone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000276	CcSEcCtD
Hydromorphone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000274	CcSEcCtD
Hydromorphone—Cough—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000272	CcSEcCtD
Hydromorphone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000272	CcSEcCtD
Hydromorphone—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00027	CcSEcCtD
Hydromorphone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000165	0.00027	CcSEcCtD
Hydromorphone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000269	CcSEcCtD
Hydromorphone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000268	CcSEcCtD
Hydromorphone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000265	CcSEcCtD
Hydromorphone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000265	CcSEcCtD
Hydromorphone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000265	CcSEcCtD
Hydromorphone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000265	CcSEcCtD
Hydromorphone—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000265	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000264	CcSEcCtD
Hydromorphone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000262	CcSEcCtD
Hydromorphone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.00026	CcSEcCtD
Hydromorphone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000159	0.00026	CcSEcCtD
Hydromorphone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000259	CcSEcCtD
Hydromorphone—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000259	CcSEcCtD
Hydromorphone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000258	CcSEcCtD
Hydromorphone—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000257	CcSEcCtD
Hydromorphone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000255	CcSEcCtD
Hydromorphone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000254	CcSEcCtD
Hydromorphone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000254	CcSEcCtD
Hydromorphone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000253	CcSEcCtD
Hydromorphone—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000252	CcSEcCtD
Hydromorphone—Shock—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00025	CcSEcCtD
Hydromorphone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00025	CcSEcCtD
Hydromorphone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00025	CcSEcCtD
Hydromorphone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000249	CcSEcCtD
Hydromorphone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000248	CcSEcCtD
Hydromorphone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000247	CcSEcCtD
Hydromorphone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000246	CcSEcCtD
Hydromorphone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000246	CcSEcCtD
Hydromorphone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000246	CcSEcCtD
Hydromorphone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000246	CcSEcCtD
Hydromorphone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000245	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000244	CcSEcCtD
Hydromorphone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000243	CcSEcCtD
Hydromorphone—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000243	CcSEcCtD
Hydromorphone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.00024	CcSEcCtD
Hydromorphone—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000238	CcSEcCtD
Hydromorphone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000237	CcSEcCtD
Hydromorphone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000235	CcSEcCtD
Hydromorphone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000234	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000232	CcSEcCtD
Hydromorphone—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000232	CcSEcCtD
Hydromorphone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000231	CcSEcCtD
Hydromorphone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00023	CcSEcCtD
Hydromorphone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00023	CcSEcCtD
Hydromorphone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000229	CcSEcCtD
Hydromorphone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000228	CcSEcCtD
Hydromorphone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000228	CcSEcCtD
Hydromorphone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000227	CcSEcCtD
Hydromorphone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000226	CcSEcCtD
Hydromorphone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000224	CcSEcCtD
Hydromorphone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000224	CcSEcCtD
Hydromorphone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000221	CcSEcCtD
Hydromorphone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00022	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000134	0.00022	CcSEcCtD
Hydromorphone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000219	CcSEcCtD
Hydromorphone—Pain—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000218	CcSEcCtD
Hydromorphone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000218	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000214	CcSEcCtD
Hydromorphone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000213	CcSEcCtD
Hydromorphone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000211	CcSEcCtD
Hydromorphone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00021	CcSEcCtD
Hydromorphone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00021	CcSEcCtD
Hydromorphone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000209	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000208	CcSEcCtD
Hydromorphone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000207	CcSEcCtD
Hydromorphone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000205	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000203	CcSEcCtD
Hydromorphone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000203	CcSEcCtD
Hydromorphone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000202	CcSEcCtD
Hydromorphone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000201	CcSEcCtD
Hydromorphone—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000201	CcSEcCtD
Hydromorphone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000201	CcSEcCtD
Hydromorphone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000201	CcSEcCtD
Hydromorphone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000194	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000193	CcSEcCtD
Hydromorphone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000187	CcSEcCtD
Hydromorphone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000187	CcSEcCtD
Hydromorphone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000186	CcSEcCtD
Hydromorphone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000186	CcSEcCtD
Hydromorphone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000183	CcSEcCtD
Hydromorphone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00018	CcSEcCtD
Hydromorphone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000174	CcSEcCtD
Hydromorphone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000173	CcSEcCtD
Hydromorphone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000169	CcSEcCtD
Hydromorphone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000168	CcSEcCtD
Hydromorphone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000167	CcSEcCtD
Hydromorphone—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.89e-05	0.000162	CcSEcCtD
Hydromorphone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.84e-05	0.000161	CcSEcCtD
Hydromorphone—Rash—Epirubicin—peripheral nervous system neoplasm	9.81e-05	0.00016	CcSEcCtD
Hydromorphone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.00016	CcSEcCtD
Hydromorphone—Headache—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000159	CcSEcCtD
Hydromorphone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000156	CcSEcCtD
Hydromorphone—Nausea—Epirubicin—peripheral nervous system neoplasm	9.24e-05	0.000151	CcSEcCtD
Hydromorphone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.00015	CcSEcCtD
Hydromorphone—Rash—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.000148	CcSEcCtD
Hydromorphone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.06e-05	0.000148	CcSEcCtD
Hydromorphone—Headache—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000147	CcSEcCtD
Hydromorphone—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.55e-05	0.00014	CcSEcCtD
